Nutriband, Inc is an innovative pharmaceutical company based in Orlando, FL, specializing in the development of transdermal drug delivery systems and devices. With a core focus on improving patient outcomes, Nutriband aims to address the global opioid epidemic by revolutionizing the safety standards for opioid-based transdermal medications through their groundbreaking technology called AVERSA.
Through their subsidiaries, 4P Therapeutics and Pocono Pharmaceutical, Nutriband has the capabilities for developing pharmaceutical products from pre-clinical testing to early stage clinical development. Their expertise lies in the development of transdermal products for compounds typically delivered via injection, offering the potential to enhance safety, efficacy, and therapeutic outcomes. With a commitment to improving patient comfort, safety, and efficacy, Nutriband is dedicated to setting new safety standards for effective medications that are often prone to abuse.
Generated from the website